Nvidia Corp vs Revvity Inc — how do they compare? Nvidia Corp trades at $219.87 (market cap $5.27T), while Revvity Inc trades at $116.5 (market cap $12.91B). The key difference: Nvidia Corp is far larger — about 408.2× Revvity Inc's market cap, and Nvidia Corp pays the higher dividend (0.46%). Which is the better fit depends on your goals.
| NVDA | RVTY | |
|---|---|---|
Market Cap | $5.27T | $12.91B |
Sector | Technology | Technology |
52-Week High | $235.75 | $117.75 |
52-Week Low | $165.17 | $82.26 |
Enterprise Value | $5.20T | $15.23B |
Dividend Yield | 0.46% | 0.24% |
Signals from Pluang's Aura AI — not financial advice
NVIDIA (NVDA) trades at $217.56, down 2.86% over the past 24 hours, with a bullish technical signal from moving averages and a neutral stance from oscillators. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $1.87 exceeding the $1.76 estimate. Revenue surged to $130.50B in 2025, driving a net income margin of 62.97% and robust cash flow from operations of $64.09B. Analyst sentiment remains overwhelmingly positive, with a consensus price target of $325.86.
The outlook for NVDA is favorable, supported by accelerating AI chip demand and a dominant market position. Key opportunities include sustained revenue growth and expanding profitability, while risks involve heightened competition, potential peak AI spending, and market volatility. The stock's current valuation metrics, such as a P/E of 33.31, reflect high growth expectations that must be met to justify further upside.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.
Read more on NVDA →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →